sábado, 30 de septiembre de 2023

3 How AI and Machine Learning Are Transforming Liver Disease Diagnosis and Treatment


World Heart Day: Mental health support crucial for people with cardiovascular disease


Reader survey to shape future of Environmental Factor newsletter


Breast cancer disparities top of mind for NIEHS grant recipient


NIEHS Sister Study 20th Anniversary Video

Advances in breast cancer research shared with NIH and the world

https://factor.niehs.nih.gov/2023/10/feature/breast-cancer-sister-study-advances-20-years?utm_medium=email&utm_source=govdelivery As Sister Study turns 20, NIEHS lead researcher highlights study’s major findings at prestigious NIH lecture.

The Lancet Respiratory Medicine in conversation with Keith Chappell on a bivalent recombinant vaccine for COVID-19


Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial


Looking ahead: New cleared concepts for aging research


Arthritis and Complementary Health Approaches


General Medicine News: Can Long COVID Lift the Veil on Chronic Fatigue Syndrome?


New on NCI’s Websites for September 2023


Clinical Trials Update from NCI, September 2023


FDA Launches Pilot Program to Help Further Accelerate Development of Rare Disease Therapies


FDA Grants First Marketing Authorization for a DNA Test to Assess Predisposition for Dozens of Cancer Types


Tainted Arthritis | Pain Products: Hidden drug ingredients identified in products marketed for pain and arthritis

https://www.fda.gov/drugs/medication-health-fraud/tainted-arthritis-pain-products?utm_medium=email&utm_source=govdelivery Kuka Flex Forte contains hidden drug ingredient https://www.fda.gov/drugs/medication-health-fraud/kuka-flex-forte-contains-hidden-drug-ingredient?utm_medium=email&utm_source=govdelivery Reumo Flex contains hidden drug ingredient https://www.fda.gov/drugs/medication-health-fraud/reumo-flex-contains-hidden-drug-ingredient?utm_medium=email&utm_source=govdelivery

Article Spotlights an Often-Neglected Part of the Body Director’s Page Helene M. Langevin, M.D.

https://www.nccih.nih.gov/about/offices/od/director/past-messages/article-spotlights-an-often-neglected-part-of-the-body?nav=govd I was so pleased to speak recently with The New York Times reporter, Danielle Friedman, for her recent story on fascia, “The Tissue That Connects Our Muscles May Be a Key to Better Health.” The role of fascia in how our bodies function and the impact on our health is a topic that hasn’t gotten enough attention, but that is beginning to change, and it’s encouraging to have a thoughtful discussion on this subject. As Ms. Friedman explained, fascia is “the tough, flexible tissue that surrounds and connects muscles, bones, and organs like cling wrap.” I’m proud of the National Center for Complementary and Integrative Health’s work to advance research on this significant yet understudied part of our bodies. Our efforts are aimed at answering questions on how the health of fascia relates to overall health and wellness, physical performance, and its relationship to chronic pain, which affects about one in five Americans.

viernes, 29 de septiembre de 2023

NIMH Expert Dr. Mary Rooney Discusses Managing ADHD in Children and Adol...

Digital Shareables on Attention-Deficit/Hyperactivity Disorder (ADHD)


FDA Office of Women’s Health College Women’s Campaign | Learn More

Mammograms Matter — 5 things to Know About Mammograms.

FDA Office of Women’s Health: Getting a Beat on What Women Know about He...

Fibroid Awareness Month | What Causes Uterine Fibroids?

College Women's Health https://www.fda.gov/consumers/take-time-care-program/college-womens-health?utm_medium=email&utm_source=govdelivery FDA Approves First Nonprescription Daily Oral Contraceptive https://www.fda.gov/news-events/press-announcements/fda-approves-first-nonprescription-daily-oral-contraceptive?utm_medium=email&utm_source=govdelivery Women and Anxiety https://www.fda.gov/consumers/free-publications-women/women-and-anxiety?utm_medium=email&utm_source=govdelivery Knowledge and News on Women: OWH Blog https://www.fda.gov/consumers/women/knowledge-and-news-women-owh-blog?utm_medium=email&utm_source=govdelivery

Facebook Live: Childhood Irritability Date/Time: November 7, 2023, 1:00–1:30 p.m. ET

https://www.nimh.nih.gov/news/events/announcements/facebook-live-childhood-irritability Date/Time: November 7, 2023, 1:00–1:30 p.m. ET Location: NIMH's Facebook Page Many children go through periods of moodiness, but children with irritability experience severe symptoms that can lead to significant problems at home and school. The National Institute of Mental Health (NIMH) is hosting a Facebook Live event on childhood irritability featuring NIMH expert Melissa Brotman, Ph.D., chief of the Neuroscience and Novel Therapeutics Unit in the Intramural Research Program. During the event, Dr. Brotman will discuss symptoms of irritability, why it's important to study irritability, NIMH-supported research in this area, and new treatments for severe irritability in youth. No registration is required for this free event. Watch the live event on NIMH’s Facebook page.


DBS for Stroke: Helping Survivors to Move Again By Ivanhoe Broadcast News on September 29, 2023 https://www.ivanhoe.com/medical-breakthroughs/dbs-for-stroke-helping-survivors-to-move-again/


Breastfeeding Benefits for Moms By Ivanhoe Broadcast News on October 8, 2023 https://www.ivanhoe.com/?p=31445&preview=1&_ppp=5a7ec8cb51


Home Remedies for Dry Eyes By Ivanhoe Broadcast News on October 7, 2023 https://www.ivanhoe.com/?p=31442&preview=1&_ppp=5f0f4521cf


I’m A Psychiatrist & This Is My Mental Health Toolkit for Myself By Ivanhoe Broadcast News on October 6, 2023 https://www.ivanhoe.com/?p=31439&preview=1&_ppp=603f463b38


Sepsis: One Nurse Makes a Difference By Ivanhoe Broadcast News on October 5, 2023 https://www.ivanhoe.com/?p=31435&preview=1&_ppp=f80053dc8b


Endometriosis: New Cause? By Ivanhoe Broadcast News on October 4, 2023 https://www.ivanhoe.com/?p=31432&preview=1&_ppp=f0bc506dc6


Alzheimer’s Risk Factors! By Ivanhoe Broadcast News on October 3, 2023 https://www.ivanhoe.com/?p=31429&preview=1&_ppp=58d29fd0de


Learning with Marlie: When Play Helps Complex Disabilities By Ivanhoe Broadcast News on October 2, 2023 https://www.ivanhoe.com/?p=31426&preview=1&_ppp=236a5264a6

jueves, 28 de septiembre de 2023

Valerian: Science and Safety


SARS-CoV-2 infects coronary arteries, increases plaque inflammation


Conversations on Cancer: Living with Metastatic Breast Cancer OCTOBER 19, 2023

Conversations on Cancer: Living with Metastatic Breast Cancer OCTOBER 19, 2023 https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/conversations-cancer-living-metastatic-breast-cancer-10192023?utm_medium=email&utm_source=govdelivery Background: FDA Oncology Center of Excellence (OCE) in conjunction with the European Medicines Agency (EMA) presents a Conversations on Cancer public panel discussion October 19, 2023, addressing the experience of living with metastatic breast cancer. Approximately 10-30% of breast cancer patients in the world are living with advanced stage or metastatic disease. With improvements in treatments and more options for therapies, many of these patients are living for years with their cancer. Cancer survivorship has become an issue of growing importance since the Institute of Medicine reported this to be an important public health issue in 2006, and it has continued to be highlighted through the more recent launch of the Cancer Moonshot in the US and the EU beating cancer plan in EU. Though many patients living with advanced breast cancer experience some of the same stressors and long-term impacts of therapies that affect all cancer survivors, they are not routinely included in cancer survivorship programs and research. The panel will feature speakers with a range of perspectives on breast cancer and, for the first time, will be an international collaboration with our colleagues at the EMA with the hope of highlighting the day-to-day, year-to-year experience of patients living with metastatic breast cancer. Some of the themes we plan to discuss include: How people find care for advanced stage breast cancer? What are the barriers to finding new treatments? What are some of the long-term effects of cancer therapies and how have they impacted patients’ choices for care? Are there mental health issues that particularly need to be addressed for patients with advanced breast cancer such as stress, difficulty sleeping, job loss? How can clinical researchers and regulators better address the key issues we have highlighted for patients living with metastatic breast cancer? Given our new collaboration with the EMA, we also hope to learn from any common threads and/or distinctions amongst patients and providers in U.S. and Europe. Webcast Information: A free-of-charge webcast of this public panel discussion will be provided. Registration for the webcast is required at: https://www.surveymonkey.com/r/SGF5FCP FDA plans to post archived webcast of this Conversations on Cancer program at: https://www.fda.gov/about-fda/project-community/conversations-cancer Contact: For any inquiries regarding this program, please send an email to: OCE-Engagement@fda.hhs.gov

Insurers Say COVID Vaccine Problems Have Been Corrected Lisa O'Mary


Does Continuity of Care Affect Outcomes After Arthroplasty? Fran Lowry


Help Those at Risk for Suicide The Department of Defense and Department of Veterans Affairs provide free and confidential nonclinical support around the clock.

Suicide Prevention Resources That Can Help https://health.mil/News/Articles/2023/09/25/Suicide-Prevention-Resources-That-Can-Help?utm_medium=govdelivery&utm_source=email

Endometriosis: What you need to know


Endometriosis under a microscope

https://magazine.medlineplus.gov/article/endometriosis-under-a-microscope?utm_medium=email&utm_source=govdelivery NIH-supported research can boost reproductive health, but it needs your help

POTS | Opioid Treatment | ME/CFS Exercise Intolerance | Advanced Care Planning | PFAS


NASA Explorers: Season 4 – Microgravity


Space to Ground: One Year Later: Sept 22, 2023

Science in Space: Week of Sept. 22, 2023 - Exposing Materials to Space


Redwire Space Successfully 3D Prints a Human Meniscus


FAQ: The International Space Station Transition Plan


ISS National Lab Highlighted by White House Cancer Moonshot Initiative

ISS National Lab Highlighted by White House Cancer Moonshot Initiative https://www.issnationallab.org/iss-national-lab-cancer-moonshot-initiative/ You’ve heard of reaching for the Moon, but the White House’s Cancer Moonshot initiative aims to do more. The recently reignited initiative has set forth an ambitious goal: to reduce the cancer death rate by at least half by 2047—which would prevent more than 4 million deaths—and improve the lives of people diagnosed with cancer. Last week, the White House released a new fact sheet of actions to move the initiative forward, and the International Space Station (ISS) National Laboratory and NASA are highlighted as key players.

miércoles, 27 de septiembre de 2023

Protein may be linked to exercise intolerance in ME/CFS


Immune response to eating chitin linked to better health


Touch-sensing protein plays role in sexual response


Biomarker tracks recovery from depression


NIH designates people with disabilities as a population with health disparities


Aligning Rhythms, Defying Alzheimer's: Intermittent Fasting's Role in Combating Alzheimer's Disease Neurodegeneration

https://www.news-medical.net/news/20230901/Aligning-Rhythms-Defying-Alzheimers-Intermittent-Fastings-Role-in-Combating-Alzheimers-Disease-Neurodegeneration.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=alzheimer_s_disease_newsletter_21_september_2023 Alzheimer's Disease Epidemiology https://www.news-medical.net/health/Alzheimers-Disease-Epidemiology.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=alzheimer_s_disease_newsletter_21_september_2023 Proteins for Neuroscience https://es.acrobiosystems.com/A1536-Proteins-for-Neuroscience.html?utm_source=newsmedical&utm_medium=email&utm_campaign=1451Ao23&utm_content=TGJXEN5316&utm_term=Sep_Alzheimer

Combined, high maternal stress and prenatal COVID-19 infection may affect attention span in infants


RAISE-ing the Standard of Care for Schizophrenia: The Rapid Adoption of Coordinated Specialty Care in the United States


Women, power, and cancer


The Lancet Oncology Commission on global cancer surgery: pragmatic solutions to improve cancer surgery outcomes worldwide Tuesday, November 14, 2023


Women, power, and cancer: A Lancet Commission


Mammography | Finding Cancer with Bacteria | Alcohol Use, Cancer Information Highlights, 09/27/2023


Community Voices: Forging the Path Forward for HIV Self-testing and Personalized Viral Load Monitoring

Join NIH OAR's November 1-2: Workshop on HIV Self-testing and Viral Load Monitoring https://oar.nih.gov/nih-virtual-workshop-community-voices-2023

Researchers Develop a Potential “Universal” CAR T-Cell Therapy for Blood Cancers


Annual Report to the Nation Part 2: New cancer diagnoses fell abruptly early in the COVID-19 pandemic

https://www.cancer.gov/news-events/press-releases/2023/annual-report-to-the-nation-part-2-pandemic-cancer-diagnoses?cid=eb_govdel Annual Report to the Nation: Cancer deaths continue downward trend; modest improvements in survival for pancreatic cancer https://www.cancer.gov/news-events/press-releases/2022/annual-report-to-the-nation-2022

martes, 26 de septiembre de 2023

Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV


Mental Health Matters Podcast: Understanding and Preventing Youth Suicide


Somatic Cell Genome Editing (SCGE)


Revolutionizing Technology to Treat Genetic Diseases: The NIH TARGETED Challenge Posted on September 26th, 2023 by Lawrence Tabak, D.D.S., Ph.D. and Douglas M. Sheeley, Sc.D., NIH Common Fund


Treating Migraines: Ways to Fight the Pain with Medication


The painful truth of gout in the UK The Lancet Rheumatology


From profit to impact: lives saved and the future of RSV vaccine development Natalie Mazur,Yvette Löwensteyn


Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States


The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis


Ending cancer is personal

https://gifts.mdanderson.org/Default.aspx?tsid=26620&noamt=true&chosen=100&source=e24003&utm_source=appeal&utm_medium=email&utm_campaign=FY24-09-SeptemberGratitude&utm_content=EM2&utm_keyword=body1&sm_guid=NjQ4NjA0fDE5NTY0MTg1fC0xfGNlcmFzYWxlMzE0QGdtYWlsLmNvbXw2MzA0NjUzfHwwfDB8MTc4NDIxMzg4fDk0MXwwfDB8fDY0MTg5N3ww0 I recently invited you to post the name of a loved one affected by cancer on the MD Anderson Cancer Center honor wall. I hope you will take this opportunity to honor someone you miss, pay tribute to someone affected by cancer today or share your wishes for a cancer-free future for generations to come. No one should face cancer alone. The honor wall represents our shared mission to end this devastating disease for everyone we know and love. Your post is sure to remind others that we are all in this together.

Treat Urinary Symptoms, Improve Survival? Jake Remaly


ADHD Underappreciated in Older Adults Marcus A. Banks


Psychedelic Experience and 'Oneiroid' State Lasha Khetsuriani, MD


Custom-made Cancer Therapy: Neoantigen Vaccines: Tailored Targeting Medscape TV Episode September 25, 2023


Don't Assume Newer Is Better for All -- Randomize: Lessons From FRAIL-AF John M. Mandrola, MD; Geert-Jan Geersing, MD, PhD; Linda Joosten, MD, MSc


Are Ketogenic Supplements the Key to Healthy Aging? Ann Thomas, MD, MPH


Pneumonia, Not Just Inflammation, May Cause Severe COVID Lisa Mulcahy


Dr Kilburn on Findings From the FIREFLY-1 Trial of Tovorafenib in Pediatric Low-Grade Glioma


Open Phase I and II Clinical Trials

https://childrensnational.org/departments/center-for-cancer-and-blood-disorders/programs-and-services/oncology/clinical-trials The Children's National Center for Cancer and Blood Disorders offers access to novel trials and therapies, some of which are only available at Children's National. With research interests covering nearly every aspect of pediatric cancer care, our work is making great advancements in childhood cancer.

Researchers publish first-ever atlas of cancerous mutations in histones

VIDEO: Researchers publish first-ever atlas of cancerous mutations in histones Leading genetic researchers at Children’s National Hospital have published the first pan-cancer atlas of key mutations that can drive molecular changes leading to tumors, creating a roadmap that could lead to new treatments for brain tumors and other cancers. https://innovationdistrict.childrensnational.org/researchers-publish-first-ever-atlas-of-cancerous-mutations-in-histones/

lunes, 25 de septiembre de 2023

Persistence to anti-CGRP monoclonal antibodies and onabotulinumtoxinA among patients with migraine: a retrospective cohort study


Neuroimaging in the pre-ictal or premonitory phase of migraine: a narrative review


The Journal of Headache and Pain


National Substance Use and Mental Health Services Survey (N-SUMHSS) 2022: Data on Substance Use and Mental Health Treatment Facilities


20-I-0160—Dose-Escalation Study of a Low Pathogenicity Avian H10N7 Influenza Virus in a Healthy Human Challenge Model

https://www.niaid.nih.gov/clinical-trials/20-i-0160-dose-escalation-study-low-pathogenicity-avian-h10n7-influenza-virus?utm_medium=social&utm_source=govdelivery&utm_campaign=clinicaltrail_influenzavirus_9252023 NIAID is enrolling healthy, nonsmoking adults 18-50 years of age for an inpatient flu study. The study is being conducted by NIAID and will take place at the National Institutes of Health Clinical Center in Bethesda, MD. There is no cost to participate and compensation may be provided.

Alcohol, Dengue, and Psychotropic Drugs: This Week’s EU Highlights


High Incidence of Sexual Violence Among Asylum-Seeking Women After Arrival in France


The latest research news from the National Institute on Aging at NIH


Hearing aids slow cognitive decline in people at high risk

https://www.nia.nih.gov/news/hearing-aids-slow-cognitive-decline-people-high-risk?utm_source=nia-eblast&utm_medium=email&utm_campaign=news-20230925 NIH-funded research team found that hearing aids reduced the rate of cognitive decline in older adults at high risk of dementia by almost 50% over a three-year period.

Webinar – Innovating for Inclusion: Making Clinical Research More Diverse October 31, 2023

https://www.nia.nih.gov/news/webinar-innovating-inclusion-making-clinical-research-more-diverse?utm_source=nia-eblast&utm_medium=email&utm_campaign=rd2023-20230925 Register for the NIA webinar on Oct. 31 from 2 to 2:45 p.m. ET. Speakers will offer their insights and resources to help support the inclusion of more diverse participants in dementia research.

Do stroke and hypertension mediate associations between exposure to air pollutants and dementia?


Is the implementation of contact precautions crucial for preventing healthcare-associated MRSA?


Genetic link between migraines and breast cancer risk uncovered


What makes the IPIC congress a rare gem?


Risk factors for post‐caesarean nausea and vomiting: a prospective prognostic study


Fibroblast activation protein as a potential theranostic target in brain metastases of diverse solid tumours


Effectiveness of Bundled Hyperpolypharmacy Deprescribing Compared With Usual Care Among Older Adults A Randomized Clinical Trial


In Reply: Microsurgery Versus Microsurgery With Preoperative Embolization for Brain Arteriovenous Malformation Treatment: A Systematic Review and Meta-Analysis


Risk factors for burn contractures: A cross-sectional study in a lower income country


Circular RNA hsa_circ_0098181 inhibits metastasis in hepatocellular carcinoma by activating the Hippo signaling pathway via interaction with eEF2


domingo, 24 de septiembre de 2023

Updated COVID-19 Vaccine Now Available in US, Recommended for Everyone Older Than 6 Months R Rubin, JAMA, September 18, 2023


How to Talk to Your Family About Their Heart Health History Even if you’re not super close to your relatives, you’ve got options. K Miller, Self, September 2023


Are You Up to Date on Your Preventive Care? CDC, July 2023


Factors associated with adherence to BRCA1/2 mutation testing after oncogenetic counseling in long-surviving patients with a previous diagnosis of breast or ovarian cancer. Silvia Actis et al. J Community Genet 2023 9


An interpretable deep learning framework for predicting liver metastases in postoperative colorectal cancer patients using natural language processing and clinical data integration. Jia Li et al. Cancer Med 2023


Building off ChatGPT Popularity, Generative AI Starts Finding its Place in Genome Informatics Versel N. GenomeWeb, Sep 20, 2023.


A Multicenter Analysis of Abnormal Chromosomal Microarray Findings in Congenital Heart Disease. Benjamin J Landis et al. J Am Heart Assoc 2023 e029340


Muscular Dystrophy Awareness Month: Read CDC Information

https://www.cdc.gov/ncbddd/musculardystrophy/index.html Muscular dystrophies are a group of genetic disorders that result in muscle weakness over time. Each type of muscular dystrophy is different from the others. It is important to get help as early as possible. Muscular dystrophy has no cure, but acting early may help an individual with muscular dystrophy get the services and treatments he or she needs to lead a full life.

Sickle Cell Disease Awareness Month: Read CDC Information

https://www.cdc.gov/ncbddd/sicklecell/index.html Sickle cell disease (SCD) is a group of inherited red blood cell disorders. In SCD, the red blood cells become hard and sticky and look like a C-shaped farm tool called a “sickle.” People with SCD can live full lives and enjoy most of the activities that other people do. If you have SCD, it’s important to learn how to stay as healthy as possible.

Heart Disease, Family Health History, and Familial Hypercholesterolemia

https://www.cdc.gov/genomics/disease/fh/index.htm Familial Hypercholesterolemia https://www.cdc.gov/genomics/disease/fh/FH.htm Familial hypercholesterolemia (FH) is a genetic disorder that affects about 1 in 250 people and increases the likelihood of having coronary heart disease at a younger age.

Orphanet Journal of Rare Diseases


Commonly prescribed antidepressants and how they work


The Structure and Function of the Thymus


Certain gut microbes may be linked to skeletal health


Is hemp the superfood vegetarians have been waiting for?


sábado, 23 de septiembre de 2023

EURORDIS Open Academy School on Medicines Research & Development

https://openacademy.eurordis.org/summer-school/ 2024 Open Academy Our two Open Academy Schools, taking place on 3-7 June 2024 in Barcelona, will offer rare disease-specific training to patient advocates from across Europe on the topics of 'Medicines Research & Development' and 'Scientific Innovation & Translational Research'. Make sure to submit your application by 27 October! EURORDIS Open Academy School on Scientific Innovation & Translational Research https://openacademy.eurordis.org/winter-school/

Newborn screening

https://www.eurordis.org/our-priorities/diagnosis/newborn-screening/ Newborn screening 94% of people who live with a rare disease and those close them support the diagnosis of a medical condition at a child's birth. Newborn screening is important to many people living with a rare disease and their families. This month, EURORDIS has focused on campaigning for the harmonisation of criteria and adequate policies for newborn screening across Europe. Support our efforts by joining the conversation using the hashtag #Screening4Rare on social media.

DRAFT PROGRAMME - Conference on Rare diseases and the European reference networks

DRAFT PROGRAMME - Conference on Rare diseases and the European reference networks 11 October 2023 - CONFERENCE Rare diseases and the European reference networks: how to guarantee European solidarity for patients? 9:00-9:30 Opening session https://www.eesc.europa.eu/en/agenda/our-events/events/conference-rare-diseases-and-european-reference-networks/programme Spanish EU Presidency On 10-11 October in Bilbao, the Spanish Presidency of the EU Council and the European Economic and Social Committee (EESC) will be hosting the 'Conference on Rare diseases and the European Reference Networks'. Among the speakers of the conference will be the Spanish Minister for Health, José Miñones Conde, and our Chief Executive Officer, Yann Le Cam. Read the programme.

Union of equality: Commission proposes European Disability and Parking Card valid in all Member States

https://ec.europa.eu/commission/presscorner/detail/en/ip_23_4331 EU Disability Card This month, the European Commission launched its legislative proposal for expanding the European Disability Card across the EU, to ensure access to a range of services under preferential conditions for EU citizens with disabilities. EURORDIS welcomed the proposal as an "important step in the right direction", but not without also noting that the proposal "should have been more ambitious". EURORDIS: Commission’s Disability Card plans are promising, but implementation will be key https://www.eurordis.org/eurordis-response-disability-card/

Every patient has a unique story

https://www.braverare.com/ Our friends at the Healthcare Education Institute recently launched the Brave RARE Ukraine project, which is sharing the stories of displaced Ukrainians living with complicated, chronic, and often life-threatening diseases. The project, of which EURORDIS is a partner, is aiming to raise awareness of the challenges they are facing, and how they can be overcome. https://eduinstitute.org/

Take the EURORDIS Access Campaign Questionnaire

https://www.eurordis.org/access-campaign-questionnaire/ Treatment Access The EURORDIS Access Campaign Questionnaire is inviting anybody living with a rare disease to share the difficulties they may be facing in accessing medicines, medical devices, surgeries, or medical consultations. The responses will help us uncover the hurdles to treatment that exist, toward the aim of improving access to treatments across Europe. Complete the questionnaire by 30 October.

Training for patient representatives and advocates on leadership and communication skills 26 October 2023 - 09:00 Gdańsk, Poland


Conference on Rare diseases and the European reference networks

https://www.eesc.europa.eu/en/agenda/our-events/events/conference-rare-diseases-and-european-reference-networks 11 October: Conference – "How to guarantee European solidarity for patients?" | Euskalduna Conference CentreBilbaoSpain

Pharma Firms Can Sue Competitors For Violating Orphan Exclusivity, German Court Rules

https://archive.ph/4iDGi#selection-1289.0-1289.85 Simone Boselli, our Public Affairs Director, has spoken to Pink Sheet, a news outlet covering pharmaceutical affairs, about a recent German court ruling relating to pharmaceutical companies suing their competitors for violating market exclusivity in the orphan drug market. Simone told Pink Sheet that while the enforcement of EU regulations in this area is welcome, "sidelining questions around affordability would be an error". Joint HTA And Pricing: How To Make Specialized Treatments like Strimvelis Affordable https://pink.citeline.com/PS122335/Joint-HTA-And-Pricing-How-To-Make-Specialized-Treatments-like-Strimvelis-Affordable

The IRDiRC Chrysalis Task Force: making rare disease research attractive to companies

https://journals.sagepub.com/doi/10.1177/26330040231188979 The Chrysalis Task Force launched by the International Rare Diseases Research Consortium (IRDiRC) - of which EURORDIS is a member - has produced an article identifying the key financial and non-financial factors that make rare disease research and development more attractive to companies. The Task Force is comprised of thought leaders from companies, patient advocacy groups, regulatory agencies, and research funders. https://irdirc.org/

Avicenna Days (AAD) 2023

https://www.avicenna-alliance.com/avicenna-days/avicenna-days-aad-2023.html The Avicenna Alliance, an association of industry, academic and healthcare organisations who have an interest in the development of in silico medicine, will be hosting the Avicenna Days 2023 conference from 10-12 October. Day 3 of the conference, titled 'Involving and serving the patients', will feature a diverse range of speakers on catalysing medical innovation through patient engagement, including Veronica Popa, our Digital Patient Engagement Manager at EURORDIS. The event is online and free to attend.

Living Life to the Full – Life with Kearns Sayre syndrome

https://www.eurordis.org/life-with-kearns-sayre/ This week, we published an article telling Victor Valkov's story. Viktor is 22, living in Bulgaria with Kearns Sayre syndrome, yet does not let this impact his outlook on life. Viktor diligently follows his mito cocktail regimen, primarily consisting of supplements and vitamins, while doing physiotherapy five times a week and swimming each weekend. He knows that his efforts have long-term benefits and tries hard to complete his daily tasks as best as he can. Read more stories from our community. Would you like to share your story with us about life with a rare disease to support our Community article series? Contact Rhiannon Walls, our Communications Junior Manager, at rhiannon.walls@eurordis.org.

Measuring how living with a rare disease impacts our mental health

https://www.mhe-sme.org/measuring-how-living-with-a-rare-disease-impacts-our-mental-health/ Mental health and living with NF1 Claas Röhl, the father of a daughter with Neurofibromatosis Type 1 (NF1), has written for Mental Health Europe about the specific mental health strains of a rare disease on individuals and their families. NF1 is a genetic disorder that causes tumours to grow along nerves, and Claas is the President of NF Kinder, an organisation committed to improving the lives of people with the condition. NF Kinder have also recently launched their campaign, 'The Many Faces of the NF', which is raising awareness of NF1 and features people living with the condition, their relatives, and their doctors.

September is….Leukodystrophy Awareness Month

https://alextlc.org/september-is-leukodystrophy-awareness-month/ Leukodystrophy Awareness Month takes place every year throughout September, and aims to spread awareness of everyone affected by leukodystrophy. Leukodystrophy refers to the group of rare genetic disorders characterised by the progressive degeneration of white matter in the brain, leading to neurological and motor dysfunction. Leukodystrophy Awareness Month provides an opportunity to raise awareness of leukodystrophy, including the symptoms of leukodystrophy, the impact of the condition on individuals and families.

International Ataxia Awareness Day – September 25, 2023

https://nationaltoday.com/international-ataxia-awareness-day/ International Ataxia Awareness Day (IAAD) is a coordinated effort from individuals and Ataxia organizations around the world to help shed light on this rare disease. A great way to spread awareness is to encourage people to learn about Ataxia. Share what you know about Ataxia and your experiences. Is your organisation also aware of any upcoming awareness events that you would like to see promoted in the Community section of our monthly newsletter? If yes, contact our Communications Manager, Julien Poulain, at julien.poulain@eurordis.org.

Genes to Mental Health Network Open Session Meeting Date/Time: September 26, 2023, 8:30 a.m.–12:30 p.m. ET

Genes to Mental Health Network Open Session Meeting Date/Time: September 26, 2023, 8:30 a.m.–12:30 p.m. ET https://www.eventbrite.com/e/genes-to-mental-health-network-open-session-meeting-tickets-715346640057?aff=oddtdtcreator The Genes to Mental Health (G2MH) Network initiative was established in 2019 under RFA-MH-19-200 and RFA-MH-19-201 . The program aims to investigate the behavioral and cognitive symptoms in individuals with rare genetic variants that confer a high risk for neurodevelopmental psychiatric disorders for characterizing genotype-to-phenotype relationships. During the annual meeting, this open session will feature research progress presentations from the G2MH Network investigators.

Technical Assistance Webinar: Approaches to Identifying Preteen Suicide Risk and Protective Factors

https://www.nimh.nih.gov/news/events/announcements/technical-assistance-webinar-approaches-to-identifying-preteen-suicide-risk-and-protective-factors A technical assistance webinar will be held for prospective applicants of the following Notice of Funding Opportunities (NOFOs): Approaches to Identifying Preteen Suicide Risk and Protective Factors (R01 Clinical Trial Not Allowed) and Data Coordinating Center for Approaches to Identifying Preteen Suicide Risk and Protective Factors (U24 Clinical Trial Not Allowed). National Institute of Mental Health staff will be available to answer questions related to these NOFOs. Participation in the webinar is optional and is not required to apply to these applications. No registration required! All prospective applicants are invited to attend and are highly encouraged to submit questions in advance. Please send questions to eric.murphy@nih.gov.

County-Level Sociodemographic Characteristics and Availability of COVID-19 Therapeutic Drugs

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2809728?utm_medium=email&utm_source=govdelivery An NIMHD-funded study investigating the availability of COVID-19 therapeutics across the U.S. found that there were disparities in access to these drugs. Counties with high rates of people living below the federal poverty line, individuals without health insurance, and populations with a high social vulnerability index had lower access to treatment. This was also the case for counties with high numbers of Black individuals. The findings were published in JAMA on Wednesday, September 20. The study was co-authored by NIH’s Stadtman Invesigator, Dr. Kosuke Tamura, who heads the Socio-Spatial Determinants of Health (SSDH) Laboratory in the Division of Intramural Research at NIMHD.

Strategies and Treatments for Respiratory Infections and Viral Emergencies (STRIVE)


Clinical trial to test immune modulation strategy for hospitalized covid-19 patients begins

Clinical trial to test immune modulation strategy for hospitalized covid-19 patients begins Part of NIH’s STRIVE consortium, the therapeutic may prevent overactive immune systems from causing severe symptoms. https://www.nih.gov/news-events/news-releases/clinical-trial-test-immune-modulation-strategy-hospitalized-covid-19-patients-begins A clinical trial has launched to test whether early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness is beneficial. The placebo-controlled study, part of the global clinical trials consortium known as Strategies and Treatments for Respiratory Infections and Viral Emergencies (STRIVE), will enroll approximately 1,500 people at research sites around the world. It is supported by the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) in partnership with NIH’s National Center for Advancing Translational Sciences (NCATS).A clinical trial has launched to test whether early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness is beneficial. The placebo-controlled study, part of the global clinical trials consortium known as Strategies and Treatments for Respiratory Infections and Viral Emergencies (STRIVE), will enroll approximately 1,500 people at research sites around the world. It is supported by the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) in partnership with NIH’s National Center for Advancing Translational Sciences (NCATS).

viernes, 22 de septiembre de 2023

Open Academy Schools 2024


EURORDIS Open Academy School on Scientific Innovation & Translational Research


EURORDIS Open Academy School on Medicines Research & Development


The global rare disease community calls on United Nations Member States to turn Universal Health Coverage into a reality for people living with rare diseases


Interview with Yann Le Cam: Reflecting on a Quarter Century as Chief Executive Officer



Fibromyalgia or Chronic Fatigue? By Ivanhoe Broadcast News on September 8, 2023 https://www.ivanhoe.com/family-health/fibromyalgia-or-chronic-fatigue/


You’ve Got a Degree. Now What? Helping You Get Your First Job By Ivanhoe Broadcast News on September 24, 2023 https://www.ivanhoe.com/?p=31299&preview=1&_ppp=fd351b53a3


Beyond the Bite: Tick-Borne Meat Allergies By Ivanhoe Broadcast News on September 24, 2023 https://www.ivanhoe.com/?p=31296&preview=1&_ppp=a4202048c1


Empowering A New Generation: How to Lead Gen Z By Ivanhoe Broadcast News on September 23, 2023 https://www.ivanhoe.com/?p=31293&preview=1&_ppp=0a6bdaca5b


Breathe Deep: Monitoring Air Quality By Ivanhoe Broadcast News on September 23, 2023 https://www.ivanhoe.com/?p=31290&preview=1&_ppp=6d9413eea0


Vaping & Cancer Link: The New Danger By Ivanhoe Broadcast News on September 19, 2023 https://www.ivanhoe.com/medical-breakthroughs/vaping-cancer-link-the-new-danger/


First FDA Approved Drug to Slow Alzheimer’s By Ivanhoe Broadcast News on September 20, 2023 https://www.ivanhoe.com/medical-breakthroughs/alzheimers-first-fda-approved-drug-to-slow/


Cancer Drug Shortage By Ivanhoe Broadcast News on September 21, 2023 https://www.ivanhoe.com/medical-breakthroughs/cancer-drug-shortage/


Is Smoking in Your Genes? By Ivanhoe Broadcast News on September 22, 2023 https://www.ivanhoe.com/medical-breakthroughs/is-smoking-in-your-genes/


Chroming: Dangerous Teen Trend By Ivanhoe Broadcast News on October 1, 2023 https://www.ivanhoe.com/?p=31358&preview=1&_ppp=1d409e9cd0


Money Matters: Creating Cash Savvy Kids By Ivanhoe Broadcast News on September 30, 2023 https://www.ivanhoe.com/?p=31355&preview=1&_ppp=e06e68c85d


Transition from Stay-At-Home Mom to Full-Time-Job Mom By Ivanhoe Broadcast News on September 30, 2023 https://www.ivanhoe.com/?p=31352&preview=1&_ppp=80760b1667


DBS for Stroke: Helping Survivors to Move Again By Ivanhoe Broadcast News on September 29, 2023 https://www.ivanhoe.com/?p=31406&preview=1&_ppp=099ffac78b


New Technology Saving Livers and Lives By Ivanhoe Broadcast News on September 28, 2023 https://www.ivanhoe.com/?p=31399&preview=1&_ppp=110542fcf8


BEAR Implant Preserves the ACL By Ivanhoe Broadcast News on September 27, 2023 https://www.ivanhoe.com/?p=31389&preview=1&_ppp=0ceabcf8dd


Prevent Hearing Loss: Using AI By Ivanhoe Broadcast News on September 26, 2023 https://www.ivanhoe.com/?p=31381&preview=1&_ppp=08825f4795


Colorectal Cancer on the Rise in Young By Ivanhoe Broadcast News on September 25, 2023 https://www.ivanhoe.com/?p=31375&preview=1&_ppp=6cb78db115

jueves, 21 de septiembre de 2023


Ketamine to Heal Kids’ Brains? By Ivanhoe Broadcast News on September 18, 2023 https://www.ivanhoe.com/family-health/children/ketamine-to-heal-kids-brains/

Think again: Suppressing negative thoughts may actually improve mental health


Is presence of a premenstrual disorder associated with higher risk of early menopause and menopause-related vasomotor symptoms?


Can a Drug for Overactive Bladder Disease Prevent Progression to Heart Failure? Pauline Anderson


Severe Psoriasis Linked to a Higher Risk for Heart Disease, Study Confirms Doug Brunk


Lymphedema (PDQ®)–Health Professional Version


Late Effects of Treatment for Childhood Cancer (PDQ®)–Health Professional Version


Childhood Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version


Occupational exposure to reinforced concrete production is associated with adverse respiratory health


Brazilian fruits positively impact gut health and chronic disease prevention


Does arsenic exposure cause mortality due to cancer, diabetes, Alzheimer's and congenital anomalies?


Is menopausal hormone therapy associated with non-alcoholic fatty liver disease?


Unlocking the Secrets of Blue Zones: A Blueprint for Longevity and Health


Uncontrolled hypertension wreaks havoc on global health and economies


What’s Wrong With This Picture? NIST Face Analysis Program Helps to Find Answers


Could Bacteria Help Find Cancer?


Strategizing Training and Career Opportunities in Whole Person Natural Products Research


Weight Control and Dietary Supplements


Researchers discover biomarker for tracking depression recovery


SAMHSA Releases Key Survey Findings on Recovery from Substance Use and Mental Health Problems Among Adults in the United States Today

https://store.samhsa.gov/product/recovery-from-substance-use-mental-health-problems-among-adults-in-us/pep23-10-00-001?utm_source=SAMHSA&utm_campaign=1c4d61efbf-EMAIL_CAMPAIGN_2023_09_15_04_00&utm_medium=email&utm_term=0_-1c4d61efbf-%5BLIST_EMAIL_ID%5D As part of SAMHSA’s 2023 National Recovery Month efforts, SAMHSA’s Office of Recovery has released the Recovery from Substance Use and Mental Health Problems Among Adults in the United States Report. Based on data from the National Survey on Drug Use and Health (NSDUH), an annual survey sponsored by SAMHSA, key findings from the report include: Recovery is real and possible – A significant majority (7 in 10) of adults who have had a mental health or substance use condition are in recovery and they represent over 50 million Americans. Recovery is holistic and personalized – Factors such as social supports, treatment, insurance coverage, and spirituality can be key in supporting recovery. Resilience can accompany recovery – People in recovery reported that their mental health and substance use were not significantly impacted by the COVID-19 pandemic. Conducted annually, the NSDUH provides nationally representative data on the use of tobacco, alcohol, and drugs; substance use disorders; receipt of substance use treatment; mental health issues; and the use of mental health services among the civilian, noninstitutionalized population aged 12 or older in the United States.

NIH researchers develop new method to identify potential stroke therapies


In Other Words: Sandboxes Aren’t Just for Kids BY RACHEL CROWLEY

https://biobeat.nigms.nih.gov/2023/09/in-other-words-sandboxes-arent-just-for-kids/?utm_medium=email&utm_source=govdelivery Cloudy With a Chance of Scientific Discoveries BY RACHEL CROWLEY https://biobeat.nigms.nih.gov/2022/03/cloudy-with-a-chance-of-scientific-discoveries/?utm_medium=email&utm_source=govdelivery

miércoles, 20 de septiembre de 2023

Rice-Sized Device Tests Brain Tumor’s Drug Responses During Surgery Posted on September 19th, 2023 by Lawrence Tabak, D.D.S., Ph.D.


How We Studied DNA Damage in Cooked Food — and What It Might Mean for Our Health September 20, 2023 By: Miral Dizdaroglu


The global launch of Women, power and cancer: A Lancet Commission on Women miércoles, 27 de septiembre de 2023 9:00 - 11:30 (UTC-03:00) Ciudad de Buenos Aires

https://iheid.webex.com/webappng/sites/iheid/meeting/register/00eddfcb4e684ad9b5c5a37273c57944?ticket=4832534b00000006e5fceeeb0f51bd0707ad838286b4f27f1067c7d3abf9be7a161c7cf3d342e042×tamp=1695215189458&RGID=r76ba5e10ef0689915b0e83d01e77a662 We are pleased to invite you to the virtual launch of Women, power and cancer: A Lancet Commission, on Sep 27, 2023, at 13:00 BST/11:00 EDT. Attendance is free, and you can register to attend the session here. Women, power, and cancer: A Lancet Commission applies an intersectional feminist approach to investigate, expose, and challenge the current imbalance of power in relation to cancer. The report calls for sex and gender to be included in all cancer-related policies and guidelines, making them responsive to the needs and aspirations of all women, whether they be cancer patients, care providers, researchers, or advocates. With opening remarks from Vania Wisdom, Executive Editor of The Lancet and Oncology Ambassador, and a panel discussion moderated by Richard Horton, Editor-in-Chief of The Lancet, join us as the authors discuss key findings and recommendations from the Commission.

The Lancet Gastroenterology & Hepatology in conversation with Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction


NASH drug treatment development: challenges and lessons


Diagnosis and management of ectopic varices in portal hypertension


Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trial


Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study


martes, 19 de septiembre de 2023

Prostate Cancer Symptoms, Tests and Treatments


Dialectical Behavior Therapy Decreased Suicide Attempts in Bipolar Teens Heidi Splete


Surge in Pediatric ADHD Med Errors Prompts Call for Prevention Robert Fulton


Volunteers needed for studies to advance dementia research

Volunteers needed for studies to advance dementia research https://www.alzheimers.gov/clinical-trials?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20230918 Brain Stimulation Using Light and Music for Early-Stage Alzheimer's Disease https://www.alzheimers.gov/clinical-trials/brain-stimulation-using-light-and-music-early-stage-alzheimers-disease?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20230918 Alzheimer's Prevention Registry https://www.alzheimers.gov/clinical-trials/alzheimers-prevention-registry?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20230918 Brain Health Registry https://www.alzheimers.gov/clinical-trials/brain-health-registry?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20230918 CADASIL Registry https://www.alzheimers.gov/clinical-trials/cadasil-registry?utm_source=nia-eblast&utm_medium=email&utm_campaign=clinicaltrials-20230918

NIH Releases Strategic Plan for Research on Herpes Simplex Virus 1 and 2

https://www.niaid.nih.gov/news-events/nih-releases-strategic-plan-research-herpes-simplex-virus-1-and-2?utm_campaign=+57753854&utm_content=&utm_medium=email&utm_source=govdelivery&utm_term= In response to the persistent health challenges of herpes simplex virus 1 (HSV-1) and HSV-2, today the National Institutes of Health released the Strategic Plan for Herpes Simplex Virus Research. An NIH-wide HSV Working Group developed the plan, informed by feedback from more than 100 representatives of the research and advocacy communities and interested public stakeholders. HSV-1 and HSV-2 are among the most common viral infections in the United States. There are no licensed preventive HSV vaccines, and there is no cure. The plan will advance understanding of HSV virology and accelerate development of diagnostics, vaccines, and therapies.

A potential blood test for Parkinson’s disease


Tiny implanted devices give insights for treating brain tumors


Cold virus may set the stage for Long COVID


lunes, 18 de septiembre de 2023

Decision-support tools to build climate resilience against emerging infectious diseases in Europe and beyond


Sex-specific risks for cardiovascular disease across the glycaemic spectrum: a population-based cohort study using the UK Biobank


Psychedelic-assisted psychotherapy: hope and dilemma


AI and machine learning can successfully diagnose polycystic ovary syndrome


Higher buprenorphine doses associated with improved retention in treatment for opioid use disorder


The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis


The burden of stomach cancer mortality by county, race, and ethnicity in the USA, 2000–2019: a systematic analysis of health disparities


The uneven decline of gastric cancer in the USA: epidemiology of a health disparity


The clinical pharmacist role in patients with suspected allergy to beta-lactams: A systematic review


Types of Neurons in the Human Colonic Myenteric Plexus Identified by Multilayer Immunohistochemical Coding


Dermatologists might be the first to suspect hereditary leiomyomatosis and renal cell carcinoma syndrome⋆


Normal Graft Function After Pig-to-Human Kidney Xenotransplant


Physical restraint within the prehospital Emergency Medical Care Environment: A scoping review


Five Tips for Plastic Surgery Trainees Interested in Facial Rejuvenation Selección SIIC: 07 Septiembre, 2023 Aesthetic Surgery Journal


Measuring the global burden of anaemia


Tackling the enormous global burden of anaemia


The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019


Communicable diseases across the entire developmental window of childhood and adolescence: an outstanding agenda


Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021


Measuring the global burden of diabetes: implications for health policy, practice, and research


Diabetes: a defining disease of the 21st century


Estimating the exposure–response function between long-term ozone exposure and under-5 mortality in 55 low-income and middle-income countries: a retrospective, multicentre, epidemiological study

Estimating the exposure–response function between long-term ozone exposure and under-5 mortality in 55 low-income and middle-income countries: a retrospective, multicentre, epidemiological study https://www.thelancet.com/journals/lanplh/article/PIIS2542-5196(23)00165-1/fulltext?dgcid=hubspot_update_feature_updatealerts_lanplh&utm_campaign=update-lanplh&utm_medium=email&_hsmi=274609108&_hsenc=p2ANqtz-9GARVrFPWEPRTlNVOWGb2l7As4wUVVDoIZ0LVr6VHDW2d5s8wkb53Hb3LLGx4t8TYqM5Lb9Fp_17_FG2XQTFQcikBpLw&utm_content=274412428&utm_source=hs_email

IACC Full Committee Meeting (Hybrid) Wednesday, October 11, 2023; 10:00 a.m. - 5:00 p.m. ET 6001 Executive Boulevard, Rockville, MD 20852

https://iacc.hhs.gov/meetings/iacc-meetings/2023/full-committee-meeting/october11/register.shtml The Interagency Autism Coordinating Committee (IACC) will be holding a hybrid Full Committee Meeting on Wednesday, October 11, 2023 from 10:00 a.m. to 5:00 p.m. ET in Rockville, MD. The Committee welcomes public comments, including those related to mental health and employment, which are the featured topics at the meeting. Comments are due Wednesday, September 20, 2023 at 5:00 p.m. The hybrid meeting is free and will be open to the public in-person and via NIH Videocast. For more information visit the meeting page.

domingo, 17 de septiembre de 2023

Molecular Diagnostic Yield of Exome Sequencing and Chromosomal Microarray in Short Stature: A Systematic Review and Meta-Analysis. Qing Li et al. JAMA Pediatr 2023 9


A deep learning-based electrocardiogram risk score for long term cardiovascular death and disease JW Hughes et al, NPJ Digital Medicine, September 12, 2023


Do polygenic risk scores add to clinical data in predicting pancreatic cancer? a scoping review. Louise Wang et al. Cancer Epidemiol Biomarkers Prev 2023 8


Rare variants in CAPN2 increase risk for isolated hypoplastic left heart syndrome Blue EE , White JJ , Dush MK , Gordon WW , Wyatt BH , White P , Marvin CT , Helle E , Ojala T , Priest JR , Jenkins MM , Almli LM , Reefhuis J , Pangilinan F , Brody LC , McBride KL , Garg V , Shaw GM , Romitti PA , Nembhard WN , Browne ML , Werler MM , Kay DM , Mital S , Chong JX , Nascone-Yoder NM , Bamshad MJ .


Artificial Intelligence and Machine Learning in Cancer Research: A Systematic and Thematic Analysis of the Top 100 Cited Articles Indexed in Scopus Database. Ibrahim H Musa et al. Cancer Control 2023 3010732748231195439


Temporal changes in antibiotic resistance and population structure of methicillin-resistant Staphylococcus pseudintermedius between 2010 and 2021 in the United States. Lufuno Phophi et al. Comp Immunol Microbiol Infect Dis 2023 7 102028


The effect of a prior e-learning tool on genetic counseling outcomes in diverse ethnic couples with abnormal Down syndrome screening tests: A randomized controlled trial. Olfat Aboleil-Zoubi et al. J Genet Couns 2023


A Proclamation on National Sickle Cell Awareness Month, 2023 The White House, September 2023.


Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study. External Web Site Icon Koehm Michaela, et al. RMD open 2023 0 0. (3)


Pregnant and Living with Sickle Cell Disease: A Push for Better Outcomes NIH, September 2023

https://phgkb.cdc.gov/PHGKB/specificPHGKB.action?topic=Infectious%20diseases&query=home From the website: " Experts say that medical advances in care and disease-modifying therapies have helped many people living with SCD survive well through their reproductive years. For parents-to-be, that means awareness is key. Individuals with SCD are at higher risk than the general population for preeclampsia, as Found discovered; but those with preeclampsia can go on to develop a condition called eclampsia, which can lead to seizures and even coma. People with SCD are also at higher risk for sepsis and blood clots. And there are risks for the fetus, such as lower-than-normal growth in the womb, preterm delivery, and stillbirth."

AI detects eye disease and risk of Parkinson's from retinal images. Mariana Lenharo et al. Nature 2023 9


How to Talk to Your Family About Their Heart Health History Even if you’re not super close to your relatives, you’ve got options. K Miller, Self, September 2023


Cost effectiveness review of text messaging, smartphone application, and website interventions targeting T2DM or hypertension. Ruben Willems et al. NPJ Digit Med 2023 8 (1) 150


Do polygenic risk scores add to clinical data in predicting pancreatic cancer? a scoping review. Louise Wang et al. Cancer Epidemiol Biomarkers Prev 2023 8


Heart Disease, Family Health History, and Familial Hypercholesterolemia


From Guthrie to Genomes: The Continued Evolution of Newborn Screening

https://blogs.cdc.gov/genomics/2022/08/15/from-guthrie-2/ August 15, 2022 by Amy Gaviglio, MS, CGC, 4ES Corporation, Cynthia Hinton, PhD, Suzanne Cordovado, PhD, Rosemary Hage, PhD, and Carla Cuthbert, PhD, Newborn Screening and Molecular Biology Branch, Centers for Disease Control and Prevention

Family Health History and Cancer